Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

31.0K
Overview
31.0K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

476
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
476
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

543
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
543
Hybridoma Technology01:31

Hybridoma Technology

14.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ACE2 inhibition ELISA is an effective surrogate for SARS-CoV-2 live virus neutralisation.

Vaccine·2025
Same author

Computational prediction of multiple antigen epitopes.

Bioinformatics (Oxford, England)·2024
Same author

Computational Methods to Predict Conformational B-Cell Epitopes.

Biomolecules·2024
Same author

Semi-crystalline materials for pharmaceutical fused filament fabrication: Dissolution and porosity.

International journal of pharmaceutics·2024
Same author

The Multifaceted Effects of Osteocytic TGFβ Signaling on the Skeletal and Extraskeletal Functions of Bone.

Current osteoporosis reports·2023
Same author

Validity of common physical function tests performed online for older adults.

Archives of gerontology and geriatrics·2023

Related Experiment Video

Updated: Jun 14, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

14.9K

Computational Prediction of Multiple Antigen Epitopes.

R Viswanathan, M Carroll, A Roffe

    Biorxiv : the Preprint Server for Biology
    |August 30, 2024
    PubMed
    Summary
    This summary is machine-generated.

    We developed ISPIPab, a novel antigen epitope prediction tool. ISPIPab integrates multiple methods to improve the accuracy of identifying epitopes for vaccine design and diagnostics.

    More Related Videos

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
    06:50

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

    Published on: January 26, 2024

    1.8K
    Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
    08:09

    Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

    Published on: March 24, 2017

    9.4K

    Related Experiment Videos

    Last Updated: Jun 14, 2025

    A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
    07:59

    A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

    Published on: March 25, 2014

    14.9K
    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
    06:50

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

    Published on: January 26, 2024

    1.8K
    Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
    08:09

    Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

    Published on: March 24, 2017

    9.4K

    Area of Science:

    • Immunoinformatics
    • Computational Biology
    • Structural Biology

    Background:

    • Epitope identification is crucial for vaccine design, diagnostics, and drug development.
    • Experimental epitope determination is labor-intensive and costly.
    • Current computational epitope prediction tools have limited accuracy.

    Purpose of the Study:

    • To develop an improved computational method for antigen epitope prediction.
    • To enhance the accuracy and reliability of epitope identification for medical applications.

    Main Methods:

    • ISPIPab integrates two feature-based and one docking-based prediction methods.
    • Hierarchical clustering is combined with the prediction algorithm.
    • Performance is benchmarked against existing state-of-the-art methods.

    Main Results:

    • ISPIPab demonstrates superior performance compared to individual constituent methods.
    • The method outperforms other existing state-of-the-art epitope prediction tools.
    • Hierarchical clustering aids in identifying known epitopes and discovering novel ones.

    Conclusions:

    • ISPIPab offers a more accurate and effective approach for antigen epitope prediction.
    • The tool can accelerate the discovery of immunodiagnostic reagents and vaccine candidates.
    • ISPIPab aids in uncovering novel epitope targets for further experimental validation.